Natural Capsules
NSE: NATCAPSUQ · ISIN INE936B01015 · Healthcare
₹146.24+6.23 (+4.45%)
Monday 9 November, 12:07 IST. Delayed. Source: Yahoo Finance.
Price chart
₹146.24 +6.23 (+4.45%) today
The day
- Previous close
- ₹140.01
- Open
- ₹140.10
- Day high
- ₹146.24
- Day low
- ₹139.31
Listed on NSE since 14 February 2025.
Key numbers
- Market value
- ₹152.25 Cr
- EPS (trailing)
- ₹-23.80
- Price to book
- 0.69
- Dividend yield
- 0.00%
- Debt to equity
- 0.49
- Profit margin
- -8.1%
- Beta
- 0.19
- Volume today
- 1,544
- Average volume
- 20,300
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹164.72 Cr | ₹18.45 Cr |
| FY24 | ₹151.29 Cr | ₹5.55 Cr |
| FY25 | ₹164.15 Cr | ₹61.74 L |
| FY26 | ₹183.09 Cr | ₹-24.66 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | ₹49 Cr | ₹-4 Cr | – |
| Q4 FY26Jan–Mar 2026Audited | ₹58 Cr | ₹-3 Cr | −761.7% |
| Q3 FY26Oct–Dec 2025 | ₹38 Cr | ₹0 | – |
| Q2 FY26Jul–Sep 2025 | ₹46 Cr | ₹-7 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹45 Cr | ₹-6 Cr | – |
| Q4 FY25Jan–Mar 2025Audited | ₹45 Cr | ₹52.07 L | – |
Source: Natural Capsules’s results filed with NSE, consolidated (the whole group). Net profit is the share of Natural Capsules’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss. EPS before Q1 FY26 is not shown: the share count changed (a bonus, split or merger), so it would not compare.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | March 2026 | September 2025 |
|---|---|---|
| Fixed assets | ₹277 Cr | ₹281 Cr |
| Investments | ₹3 Cr | ₹3 Cr |
| Inventories | ₹26 Cr | ₹26 Cr |
| Owed by customers | ₹71 Cr | ₹63 Cr |
| Cash and equivalents | ₹22.03 L | ₹76.05 L |
| Total assets | ₹424 Cr | ₹420 Cr |
| Borrowings | ₹114 Cr | ₹111 Cr |
| Total liabilities | ₹189 Cr | ₹175 Cr |
| Shareholders’ equity | ₹222 Cr | ₹227 Cr |
Source: Natural Capsules’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Natural Capsules
Natural Capsules Limited engages in the manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy free gelatin, shiny gelatin, sodium lauryl sulfate free gelatin, halal-certified gelatin, fast-release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It also provides pharmaceutical dosage forms in capsule dosage form for pharma and neutraceutical products. In addition, the company offers steroidal APIs and derivative salts comprising prednisolone, betamethasone, dexamethasone and hydrocortisone. Natural Capsules Limited was incorporated in 1993 and is based in Bengaluru, India.
- Industry
- Drug Manufacturers - Specialty & Generic
- Based in
- Bengaluru
- Employees
- 615
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Natural Capsules in the last day or two.
Dividends and corporate actions
All companiesNSE lists no dividends or other corporate actions for Natural Capsules.
Information only, not investment advice. Prices are delayed.